Danaher (DHR)
(Delayed Data from NYSE)
$245.80 USD
-4.61 (-1.84%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $245.80 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Earnings News For DHR
-
Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y
-
Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates
-
Danaher: Q1 Earnings Snapshot
-
Danaher Reports First Quarter 2024 Results
-
Danaher (DHR) Gears Up to Post Q1 Earnings: Is a Beat Likely?
-
Why Is Danaher (DHR) Up 6.6% Since Last Earnings Report?
-
Danaher (DHR) Q4 Earnings Beat, Biotechnology Sales Dip Y/Y
-
Danaher: Q4 Earnings Snapshot
-
Danaher (DHR) Surpasses Q4 Earnings and Revenue Estimates
-
Danaher Reports Fourth Quarter and Full Year 2023 Results
-
Danaher (DHR) Gears Up to Post Q4 Earnings: Is a Beat in Store?
-
Danaher (DHR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Danaher (DHR) Up 14.9% Since Last Earnings Report: Can It Continue?
-
Danaher's (DHR) Q3 Earnings & Revenues Beat, Decline Y/Y
-
TOP NEWS: Danaher reports sharp fall in third-quarter earnings
-
Danaher (DHR) Surpasses Q3 Earnings and Revenue Estimates
-
Danaher: Q3 Earnings Snapshot
-
Danaher Reports Third Quarter 2023 Results
-
Will Diagnostic Unit Weakness Mar Danaher's (DHR) Q3 Earnings?
-
Danaher (DHR) Q2 Earnings Beat, Sales Decline 7.7% Y/Y
-
Danaher (DHR) Q2 Earnings and Revenues Beat Estimates
-
Danaher: Q2 Earnings Snapshot
-
Danaher Reports Second Quarter 2023 Results
-
Will Low COVID-Testing Volumes Mar Danaher's (DHR) Q2 Earnings?
-
Danaher (DHR) Q1 Earnings Beat, Revenues Decline 7% Y/Y